Emerald Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Emerald Advisers's LLY Position: Q2 2026 in Review
Emerald Advisers reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $17.4K and leaving 1,339 shares worth $1.61M. The position accounts for 0.04% of the portfolio, ranked #138.
Emerald Advisers first reported a position in LLY in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.66M in Q3 2024. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Emerald Advisers held 1,339 shares of Eli Lilly worth $1.61M as of Q2 2026.
- Emerald Advisers sold 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
- Eli Lilly made up 0.04% of Emerald Advisers's portfolio in Q2 2026, its #138 holding.
- Emerald Advisers first reported a position in Eli Lilly in Q2 2013 and has held it in 19 quarters since.
- Emerald Advisers's Eli Lilly position peaked at $1.66M in Q3 2024.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.